| 
           Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
            The web pages are not kept up to date and are for demonstration purposes only. 
            For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. 
         | 
        BACK TO LIST | 
                     
  | 
                  
                     
 
  | 
                  
                     
 
  | 
               |||||||||||||||||||||||||
| Test | 16-APR-2024 | Reference Range | Unit | 
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 7.0 H | 4.6 - 6 | % | 
| Glucose [Mass/volume] in Blood | 104.3 H | 70 - 99 | mg/dL | 
| Urea nitrogen [Mass/volume] in Blood | 9.7 | 7 - 50 | mg/dL | 
| Creatinine [Mass/volume] in Blood | 1.2 | 0.9 - 1.3 | mg/dL | 
| Calcium [Mass/volume] in Blood | 9.3 | 8.5 - 10.5 | mg/dL | 
| Sodium [Moles/volume] in Blood | 139.5 | 135 - 145 | mmol/L | 
| Potassium [Moles/volume] in Blood | 3.9 | 3.5 - 5.1 | mmol/L | 
| Chloride [Moles/volume] in Blood | 105.7 | 98 - 114 | mmol/L | 
| Carbon dioxide, total [Moles/volume] in Blood | 22.8 | 22 - 32 | mmol/L | 
| Cholesterol [Mass/volume] in Serum or Plasma | 207.6 H | 125 - 200 | mg/dL | 
| Triglyceride [Mass/volume] in Serum or Plasma | 170.0 H | 0 - 150 | mg/dL | 
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 122.2 | 0 - 130 | mg/dL | 
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 51.3 | 40 - 60 | mg/dL | 
| Microalbumin/Creatinine [Mass Ratio] in Urine | 8.4 | 0 - 30 | mg/g | 
| Conclusion and Recommendations based on this report and previous findings known to us | 
|---|
| The results indicate suboptimal glycemic control (elevated HbA1c and fasting glucose), and dyslipidemia (high total cholesterol and triglycerides). Renal function, electrolytes, and urine microalbumin/creatinine ratio are within normal limits. Recommend clinical follow-up for diabetes and lipid management to reduce cardiovascular risk. |